Emorfia Gavrilidis

Level 4 607 St Kilda Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Bazedoxifene plus conjugated estrogen to treat menopausal depression-A pilot study.

Bazedoxifene plus conjugated estrogen to treat menopausal depression-A pilot study.

Journal: The Journal of pharmacology and experimental therapeutics
Published: August 28, 2024

(S)-S-adenosylmethionine in the treatment of pre-menstrual disorders in adult women: A protocol for an open-label pilot study.

(S)-S-adenosylmethionine in the treatment of pre-menstrual disorders in adult women: A protocol for an open-label pilot study.

Journal: Contemporary clinical trials communications
Published: December 28, 2023

Correction: A Prospective Cohort Study of Antipsychotic Medications in Pregnancy: The First 147 Pregnancies and 100 One Year Old Babies.

Correction: A Prospective Cohort Study of Antipsychotic Medications in Pregnancy: The First 147 Pregnancies and 100 One Year Old Babies.

Journal: PloS one
Published: August 25, 2023

The prevalence of early life trauma in premenstrual dysphoric disorder (PMDD).

The prevalence of early life trauma in premenstrual dysphoric disorder (PMDD).

Journal: Psychiatry research
Published: May 31, 2021

Dissecting the syndrome of schizophrenia: Associations between symptomatology and hormone levels in women with schizophrenia.

Dissecting the syndrome of schizophrenia: Associations between symptomatology and hormone levels in women with schizophrenia.

Journal: Psychiatry research
Published: June 27, 2019

Ondansetron - a promising adjunctive treatment for persistent schizophrenia.

Ondansetron - a promising adjunctive treatment for persistent schizophrenia.

Journal: Journal of psychopharmacology (Oxford, England)
Published: October 26, 2018

Improvement in depression with oestrogen treatment in women with schizophrenia.

Improvement in depression with oestrogen treatment in women with schizophrenia.

Journal: Archives of women's mental health
Published: September 11, 2018

Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.

Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.

Journal: Psychoneuroendocrinology
Published: May 27, 2018

Menstrual cycle irregularity and menopause status influence cognition in women with schizophrenia.

Menstrual cycle irregularity and menopause status influence cognition in women with schizophrenia.

Journal: Psychoneuroendocrinology
Published: April 18, 2018

Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.

Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.

Journal: CNS drugs
Published: March 18, 2018

Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.

Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.

Journal: Journal of affective disorders
Published: December 06, 2017

Development and validation of a new rating scale for perimenopausal depression-the Meno-D.

Development and validation of a new rating scale for perimenopausal depression-the Meno-D.

Journal: Translational psychiatry
Published: October 23, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026